Key facts
- This page summarizes Bruce C. Cozadd's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 8 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 01 Dec 2025, 18:14.
Bruce C. Cozadd - 26 Nov 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- Director
- Issuer ticker
- JAZZ
- Reported as of
- 26 Nov 2025
- Net transaction value
- -$4,219,937
- SEC form
- 4
- Accepted by SEC
- 01 Dec 2025, 18:14:23 UTC
- Prior SEC filing
- 20 Nov 2025
- Next SEC filing
- 21 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Paz Dizon, as attorney in fact For: Bruce C Cozadd
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bruce C. Cozadd filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 01 Dec 2025.
Change
- Previous filing in this sequence was filed on 20 Nov 2025.
- Current net transaction value: -$4,219,937.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001193210
Primary reporting owner
COZADD BRUCE C
- Relationship
- Director
- Address
- 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
- Signature
- By: /s/Paz Dizon, as attorney in fact For: Bruce C Cozadd
- Signature date
- 01 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $9,460,355
- Shares
- +76,689
- Change %
- +19%
- Price
- $123.36
- Shares after
- 470,021
- Date
- 26 Nov 2025
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $100,045
- Shares
- +811
- Change %
- +0.17%
- Price
- $123.36
- Shares after
- 470,832
- Date
- 26 Nov 2025
- Ownership
- Direct
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $5,428,567
- Shares
- -30,487
- Change %
- -6.5%
- Price
- $178.06
- Shares after
- 440,345
- Date
- 26 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $1,501,943
- Shares
- -8,380
- Change %
- -1.9%
- Price
- $179.23
- Shares after
- 431,965
- Date
- 26 Nov 2025
- Ownership
- Direct
- Footnotes
- F2
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $91,155
- Shares
- -507
- Change %
- -0.12%
- Price
- $179.79
- Shares after
- 431,458
- Date
- 26 Nov 2025
- Ownership
- Direct
- Footnotes
- F3
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $6,758,672
- Shares
- -38,126
- Change %
- -8.8%
- Price
- $177.27
- Shares after
- 393,332
- Date
- 26 Nov 2025
- Ownership
- Direct
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JAZZ
transaction
Derivative
Incentive Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -811
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Nov 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 811
- Exercise price
- $123.36
- Footnotes
- F5
JAZZ
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -76,689
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Nov 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 76,689
- Exercise price
- $123.36
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $177.70 to $178.685. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F2
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $178.72 to $179.705. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F3
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $179.73 to $179.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F4
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.70 to $177.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F5
These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.